Full-Time
Extraction Coordinator
AI-driven precision medicine through clinical and molecular data analysis
Junior
Research Triangle, Durham, NC, USA
- BS in the biological sciences with at least 2 years of experience
- Ability to maintain the confidentiality of patient related materials in compliance with HIPAA
- Requirements
- Excellent communication skills
- Thrives in a fast-paced environment
- Must have experience working in a molecular lab; prefer experience in Extractions
- Ability to work with others to plan and carry out scientific programs
- Self-driven and works well in an interdisciplinary team with minimal direction
- Strong desire to build products that will save lives and change the course of cancer
- In partnership with the Extractions supervisor, provide daily oversight of a cutting-edge Extractions workflow to provide high-quality next-generation sequencing data with rapid turnaround times, including tumor genomic, germline genomic, and transcriptomic sequencing
- Establish and maintain appropriate training curricula
- Schedule training and competency assessments for personnel
- Maintain CLIA and CAP compliance regarding equipment, reagents, and staff training
- Aid in quality review of samples within the NGS workflow from extraction to sequencing
- Coordinate the activities and responsibilities of leads and techs to ensure training and clinical
- Workflow are prioritized appropriately
- Participate in the extractions workflow where necessary
- Troubleshoot instrumentation
- Manage exceptions and ensure applicable quality standards are met for atypical sample types
- Other duties as assigned
Tempus Labs, Inc. is a leader in precision medicine, leveraging artificial intelligence to analyze vast clinical and molecular data, enabling physicians to deliver personalized, data-driven care. The company's advanced machine learning platform and unique solution sets facilitate the discovery, development, and delivery of optimized therapeutic options for patients. With a focus on extensive molecular profiling, Tempus has developed a robust pan-cancer tumor organoid platform and validated a liquid biopsy assay, demonstrating their commitment to transforming personalized patient care and their position at the forefront of the healthcare industry.
Company Stage
Series G
Total Funding
$1.3B
Headquarters
Chicago, Illinois
Founded
2015